04:50 PM EDT, 07/31/2026 (MT Newswires) -- Michael R Hayden, Director, on July 30, 2026, executed a purchase for 20,000 shares in Ionis Pharmaceuticals ( IONS ) for $1,058,700. Following the Form 4 filing with the SEC, Hayden has control over a total of 78,298 common shares of the company, with 54,298 shares held directly and 24,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/874015/000087401526000254/xslF345X05/edgardoc.xml